| Matthew Gorris, | |
|
Medical Center Blvd, Winston Salem, NC 27157-0001 | |
| (336) 716-2011 | |
| Not Available |
| Full Name | Matthew Gorris |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 10 Years |
| Location | Medical Center Blvd, Winston Salem, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982023172 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 2019-01264 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Carolina Baptist Hospital | Winston-salem, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wake Forest University Health Sciences | 4486564952 | 1987 |
News Archive
According to a new study the amount of good cholesterol a person has is not as important as how well that good cholesterol works to stop heart disease. Good cholesterol or High-Density Lipoprotein—also known as HDL is known to be healthy for the heart with people having high blood levels of HDL being at a lower risk of developing heart disease than people with low levels.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able to slow eye tumor growth with an existing FDA-approved drug.
Stem cell researchers at UCLA have discovered that three types of cells derived from human embryonic stem cells and induced pluripotent stem cells are similar to each other, but are much more developmentally immature than previously thought when compared to those same cell types taken directly from human tissue.
Scientists are one step closer to repairing the damage caused by brain metastasis, a major challenge in cancer treatment, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
› Verified 5 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
According to a new study the amount of good cholesterol a person has is not as important as how well that good cholesterol works to stop heart disease. Good cholesterol or High-Density Lipoprotein—also known as HDL is known to be healthy for the heart with people having high blood levels of HDL being at a lower risk of developing heart disease than people with low levels.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able to slow eye tumor growth with an existing FDA-approved drug.
Stem cell researchers at UCLA have discovered that three types of cells derived from human embryonic stem cells and induced pluripotent stem cells are similar to each other, but are much more developmentally immature than previously thought when compared to those same cell types taken directly from human tissue.
Scientists are one step closer to repairing the damage caused by brain metastasis, a major challenge in cancer treatment, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Gorris, Medical Center Blvd, Winston Salem, NC 27157-0001 Ph: (336) 716-2011 | Matthew Gorris, Medical Center Blvd, Winston Salem, NC 27157-0001 Ph: (336) 716-2011 |
News Archive
According to a new study the amount of good cholesterol a person has is not as important as how well that good cholesterol works to stop heart disease. Good cholesterol or High-Density Lipoprotein—also known as HDL is known to be healthy for the heart with people having high blood levels of HDL being at a lower risk of developing heart disease than people with low levels.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able to slow eye tumor growth with an existing FDA-approved drug.
Stem cell researchers at UCLA have discovered that three types of cells derived from human embryonic stem cells and induced pluripotent stem cells are similar to each other, but are much more developmentally immature than previously thought when compared to those same cell types taken directly from human tissue.
Scientists are one step closer to repairing the damage caused by brain metastasis, a major challenge in cancer treatment, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
› Verified 5 days ago
Shannon Mitchell St Clair, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 186 Kimel Park Dr, Winston Salem, NC 27103 Phone: 336-277-2000 Fax: 336-277-2050 | |
Dr. Kamal Hanee Henderson, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 186 Kimel Park Dr, Winston Salem, NC 27103 Phone: 336-277-2000 Fax: 336-277-2050 | |
Dr. Michael Joseph Mccormack Jr., M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2255 | |
Brooke Williams, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3333 Silas Creek Pkwy, Winston Salem, NC 27103 Phone: 336-718-8383 | |
Dr. David Defeo, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3001 Lyndhurst Ave, Winston Salem, NC 27103 Phone: 336-765-0383 Fax: 336-768-1737 | |
James Alan Senft, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2011 Fax: 336-713-9576 | |
Dr. Michael Richard Morgan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1381 Westgate Center Dr, Winston Salem, NC 27103 Phone: 336-718-7080 Fax: 336-718-0441 |